Notably, Lipro1 exhibited no significant biotoxicity (Figure 8I), but its administration markedly inhibited the anti‐tumor effects of sgFABP5, as confirmed by increased PCNA expression in Lipro1‐treated cells relative to the RFA+FSRP group (Figures 8J; S8D, Supporting Information). This evidence concerns the gene PCNA and neoplasm.